Score Overview
Explore the 2021 public Archive ranking →
Where Kazia Therapeutics Ltd ADR has ranked, year by year
Not enough ranking history to display a chart
This chart needs at least two years of available HDB Score rankings on 20 years of fundamentals. KZIA does not have enough ranked years in the public Archive through 2021.
More recent Archive years are available with Membership. Coverage varies by company and measure.
Net Income x Stock Price
Historical Returns
| Period | Price | Return |
|---|---|---|
Last Price2026-09-29 | $ 9.75 | — |
1 Year2025-09-29 | $ 7.47 | 30.52% |
5 Years2021-09-29 | $ 562.50 | -98.27% |
10 Years2016-09-29 | $ 394.00 | -97.53% |
20 Years2006-09-29 | $ 3.73K | -99.74% |
All Time1999-01-06 | $ 2.61K | -99.63% |
| Period | Last Price2026-09-29 | 1 Year2025-09-29 | 5 Years2021-09-29 | 10 Years2016-09-29 | 20 Years2006-09-29 | All Time1999-01-06 |
|---|---|---|---|---|---|---|
| Price | $ 9.75 | $ 7.47 | $ 562.50 | $ 394.00 | $ 3.73K | $ 2.61K |
| Return | — | 30.52% | -98.27% | -97.53% | -99.74% | -99.63% |
Prices are split & dividend adjusted. All values are reported in USD.
Fundamental Data
Reported in AUD
| Year | |||
|---|---|---|---|
| TTM | $ 42K | -$ 32M | $ 69M |
| 2025 | $ 42K | -$ 20M | $ 4M |
| 2024 | $ 2M | -$ 26M | $ 1M |
| 2023 | -$ 20M | $ 5M | |
| 2022 | $ 10K | -$ 25M | $ 7M |
| 2021 | -$ 8M | $ 27M | |
| 2020 | $ 988.11K | -$ 12M | $ 8M |
| 2019 | -$ 10M | $ 5M | |
| 2018 | -$ 6M | $ 5M | |
| 2017 | $ 8M | -$ 10M | $ 14M |
| 2016 | $ 4M | -$ 12M | $ 33M |
| 2015 | $ 89K | -$ 7M | $ 44M |
| 2014 | $ 87K | -$ 7M | $ 2M |
| 2013 | $ 1M | -$ 1M | $ 8M |
| 2012 | $ 1M | $ 1M | $ 8M |
| 2011 | $ 2M | -$ 6M | $ 6M |
| 2010 | $ 9M | -$ 12M | $ 15M |
| 2009 | $ 11M | -$ 18M | $ 33M |
| 2008 | $ 13M | -$ 20M | $ 34M |
| 2007 | $ 17M | -$ 20M | $ 39M |
| 2006 | $ 13M | -$ 16M | $ 33M |
| 2005 | $ 17M | -$ 12M | $ 47M |
| 2004 | $ 16M | -$ 12M | $ 58M |
| 2003 | $ 32M | -$ 10M | $ 30M |
| 2002 | $ 19M | -$ 14M | $ 39M |
| 2001 | $ 58M | -$ 42M | $ 61M |
| 2000 | $ 26M | -$ 13M | $ 28M |
| IPO1999 | $ 19M | -$ 17M | $ 29M |
Kazia Therapeutics Ltd ADR fundamental performance
Between 2015 and 2025, revenue declined from $ 89K to $ 42K and net income went from -$ 7M to -$ 20M. Revenue increased in 3 of those 10 years; net income in 5.
Across Kazia Therapeutics Ltd ADR's full reported history, from 1999 to 2025, revenue declined from $ 19M to $ 42K and net income went from -$ 17M to -$ 20M. Revenue increased in 40% of the years measured; net income in 52%.
Kazia Therapeutics Ltd ADR currently holds a 20-year HDB Score of 2.5 out of 10. How the HDB Score is calculated.
Membership
Continue KZIA’s history
The public Archive runs through 2021. Membership adds recent and current rankings.
- Recent and current rankings across 3,814 companies
- Compare companies with the latest data
- Track your research shortlist in a portfolio
